What payment methods are accepted?

We accept LC, T/T, PayPal, Western Union, Small-amount payment, and Money Gram.

Supply High Quality Medetomidine HCl Powder Material CAS#86347-15-1

Name: Supply High Quality Medetomidine HCl Powder Material CAS#86347-15-1
Brand: Zhejiang Multinpharma Co., Ltd.
SKU: 2239489325

Zhejiang, ChinaZhejiang Multinpharma Co., Ltd.

US$1.00-300.00

1 kg

Sample price:US$50.00/gram.Request sample

Product profile

CAS No.

86347-15-1

Formula

C13h17cln2

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Refined

Colour

Transparent

Sample

Small Quantities Available

Packing

PE Bag, Aluminium Foil Bag

Testing

HPLC, Gc, Nmr

Color

White

Transport Package

PE Bag, Foil Aluminum Bag, Cardboard Drum

Specification

10g, 20g, 50g, 100g, 500g

Trademark

Origin

China

HS Code

2937290090

Production Capacity

500kgs /Month

Key features

Veterinary Medicine Use: Alpha-2 adrenergic agonist used for analgesic and sedative properties.

Flexible Sample Order: Small quantities available for sample testing and evaluation.

Comprehensive Testing: Quality verified via HPLC, GC, and NMR testing methods.

Secure Packaging: Available in PE Bag or Aluminium Foil Bag for safe delivery.

Fast Lead Time: Peak and off-season delivery within 15 workdays.

Global Shipping: Export from Shanghai or Ningbo with FOB, EXW, CFR, CIF, DDP terms.

Company profile

Zhejiang Multinpharma Co., Ltd.Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2008-11-05Nearest Port: Shanghai, NingboAverage Response Time: ≤3.12hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP

AI-Powered supplier vetting

SummaryThe supplier is a science and technology company focused on pharmaceutical and chemical production technology services, CRO customization, continuous-flow microreaction technology, and microreaction equipment solutions. It reports broad customization, 3D software design, ODM, OEM for well-known brands, and SDK capabilities. Production information includes three production lines, stated pharmaceutical and chemical capacity, and documented finished-product inspection procedures. Management and service procedures are documented for supplier assessment, corrective actions, and complaint handling, although the approved-supplier list lacks approval signatures or dates. The supplier holds multiple stated management-system certifications. Evidence of overseas service infrastructure is absent, and no new products were reported during the past year. Customer-specific cases are not identified.

Supplier typeThe supplier is described as a science and technology company providing pharmaceutical and chemical production technology services, CRO customization, continuous-flow microreaction services, and overall microreaction equipment solutions. Its stated business scope also covers technology development, specialized chemical and pharmaceutical equipment, machinery, and related technical services, indicating a technology/service-oriented manufacturer and solution provider.

CertificationsThe supplier lists BSCI, TS 16949, ISO 14001, ISO 9001, ISO 20000, GMP, and QC 080000 certifications. The provided information explicitly confirms multiple certification holdings, although certificate validity, scope, and issuing bodies are not supplied.

After-Sales capabilityThe supplier has written procedures and records for service-capability assessment, corrective and preventive actions, and effective customer-complaint handling. However, it reports no overseas warehouse, showroom, overseas agent or branch, and no prior offline trade-show participation; therefore, documented service processes exist but overseas physical support is not demonstrated.

R&D capabilityThe supplier provides 3D software design, ODM services, an available SDK, and technology research and development related to pharmaceutical, chemical, biotechnology, and microreaction applications. Nevertheless, it explicitly reports no new products during the past year, so current technical capability is evident while recent product innovation is not demonstrated.

Production capacityThe supplier reports three production lines and annual pharmaceutical and chemical capacity entries of 100,000 tons, 200,000 tons, and 200,000 tons, supported by processing-line and stirrer facilities. It also states that finished products are inspected under written instructions that are uniformly followed, indicating documented production and quality-control practices.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, minor customization, full customization, and flexible customization. Its stated CRO customization, 3D software design, ODM, and microreaction-equipment solution services further support broad customization capability.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of experience serving brand customers. However, no customer names, project descriptions, product details, or verifiable case records are provided, so the breadth and quality of customer cases cannot be independently assessed.